TY - JOUR
T1 - The chemokine CXCL14 (BRAK) stimulates activated NK cell migration
T2 - Implications for the downregulation of CXCL14 in malignancy
AU - Starnes, Trevor
AU - Rasila, Kanwaldeep Kaur
AU - Robertson, Michael J.
AU - Brahmi, Zacharie
AU - Dahl, Richard
AU - Christopherson, Kent
AU - Hromas, Robert
N1 - Funding Information:
These studies were supported by National Institutes of Health RO1 grants HL075783 and HL66308 and the Leukemia and Lymphoma Society SCOR 7388-06 to RH.
PY - 2006/8
Y1 - 2006/8
N2 - Objective: The primary function of chemokines is the regulation of leukocyte trafficking by stimulating directional chemotaxis. The chemokine CXCL14 (BRAK) is highly expressed in all normal tissues, but is not expressed in most malignant tissues. The chemotactic activity of CXCL14 has been difficult to characterize. Recently it was reported that CXCL14 is a chemoattractant for activated monocytes and immature dendritic cells. Given that CXCL14 is downregulated upon transition to malignancy, we sought to characterize whether CXCL14 might play a role in NK cell chemotaxis. Methods: Human natural killer (NK) cells were isolated from buffy coats obtained from normal volunteers and were activated with lymphocyte conditioned media, IL-2, and ionomycin. Standard transwell chemotaxis assays, proliferation assays, and chromium release cell cytotoxicity assays were performed. Results: CXCL14 was found to stimulate migration of activated human NK cells in transwell chemotaxis assays by 1.4-fold. Similarly, it increased migration of an IL-2-dependent natural killer leukemia (NKL) cell line by 1.9-fold. Antisera against CXCL14 or pertussis toxin blocked this chemotactic effect. However, CXCL14 did not affect the proliferation or cytotoxic activity of normal human NK cells. CXCL14 also stimulated the chemotaxis of immature monocyte-derived dendritic cells. Conclusions: CXCL14 may play a role in the trafficking of NK cells to sites of inflammation or malignancy. In addition, the downregulation of the expression of CXCL14 might be an important step in successful oncogenesis to prevent NK immune surveillance of the malignancy.
AB - Objective: The primary function of chemokines is the regulation of leukocyte trafficking by stimulating directional chemotaxis. The chemokine CXCL14 (BRAK) is highly expressed in all normal tissues, but is not expressed in most malignant tissues. The chemotactic activity of CXCL14 has been difficult to characterize. Recently it was reported that CXCL14 is a chemoattractant for activated monocytes and immature dendritic cells. Given that CXCL14 is downregulated upon transition to malignancy, we sought to characterize whether CXCL14 might play a role in NK cell chemotaxis. Methods: Human natural killer (NK) cells were isolated from buffy coats obtained from normal volunteers and were activated with lymphocyte conditioned media, IL-2, and ionomycin. Standard transwell chemotaxis assays, proliferation assays, and chromium release cell cytotoxicity assays were performed. Results: CXCL14 was found to stimulate migration of activated human NK cells in transwell chemotaxis assays by 1.4-fold. Similarly, it increased migration of an IL-2-dependent natural killer leukemia (NKL) cell line by 1.9-fold. Antisera against CXCL14 or pertussis toxin blocked this chemotactic effect. However, CXCL14 did not affect the proliferation or cytotoxic activity of normal human NK cells. CXCL14 also stimulated the chemotaxis of immature monocyte-derived dendritic cells. Conclusions: CXCL14 may play a role in the trafficking of NK cells to sites of inflammation or malignancy. In addition, the downregulation of the expression of CXCL14 might be an important step in successful oncogenesis to prevent NK immune surveillance of the malignancy.
UR - http://www.scopus.com/inward/record.url?scp=33746095784&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33746095784&partnerID=8YFLogxK
U2 - 10.1016/j.exphem.2006.05.015
DO - 10.1016/j.exphem.2006.05.015
M3 - Article
C2 - 16863917
AN - SCOPUS:33746095784
SN - 0301-472X
VL - 34
SP - 1101
EP - 1105
JO - Experimental Hematology
JF - Experimental Hematology
IS - 8
ER -